Literature DB >> 21373988

Early events of HIV-1 infection: can signaling be the next therapeutic target?

Kate L Jones1, Redmond P Smyth, Cândida F Pereira, Paul U Cameron, Sharon R Lewin, Anthony Jaworowski, Johnson Mak.   

Abstract

Intracellular signaling events are signposts of biological processes, which govern the direction and action of biological activities. Through millions of years of evolution, pathogens, such as viruses, have evolved to hijack host cell machinery to infect their targets and are therefore dependent on host cell signaling for replication. This review will detail our current understanding of the signaling events that are important for the early steps of HIV-1 replication. More specifically, the therapeutic potential of signaling events associated with chemokine coreceptors, virus entry, viral synapses, and post-entry processes will be discussed. We argue that these pathways may represent novel targets for antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21373988     DOI: 10.1007/s11481-011-9268-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  190 in total

1.  Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

Authors: 
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 4.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

5.  Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes.

Authors:  Mélanie R Tardif; Michel J Tremblay
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

6.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5.

Authors:  M Farzan; H Choe; K A Martin; Y Sun; M Sidelko; C R Mackay; N P Gerard; J Sodroski; C Gerard
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

8.  Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain.

Authors:  M Farzan; H Choe; E Desjardins; Y Sun; J Kuhn; J Cao; D Archambault; P Kolchinsky; M Koch; R Wyatt; J Sodroski
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

Review 10.  Host cell factors in HIV replication: meta-analysis of genome-wide studies.

Authors:  Frederic D Bushman; Nirav Malani; Jason Fernandes; Iván D'Orso; Gerard Cagney; Tracy L Diamond; Honglin Zhou; Daria J Hazuda; Amy S Espeseth; Renate König; Sourav Bandyopadhyay; Trey Ideker; Stephen P Goff; Nevan J Krogan; Alan D Frankel; John A T Young; Sumit K Chanda
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  6 in total

1.  Cell signaling pathways and HIV-1 therapeutics.

Authors:  Johnny J He
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-30       Impact factor: 4.147

Review 2.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

3.  Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.

Authors:  Jason A Wojcechowskyj; Jessica Y Lee; Steven H Seeholzer; Robert W Doms
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

4.  Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.

Authors:  Fei Yi; Jia Guo; Deemah Dabbagh; Mark Spear; Sijia He; Kylene Kehn-Hall; Jacque Fontenot; Yan Yin; Mathieu Bibian; Chul Min Park; Ke Zheng; Ha Jeung Park; Veronica Soloveva; Dima Gharaibeh; Cary Retterer; Rouzbeh Zamani; Margaret L Pitt; John Naughton; Yongjun Jiang; Hong Shang; Ramin M Hakami; Binhua Ling; John A T Young; Sina Bavari; Xuehua Xu; Yangbo Feng; Yuntao Wu
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

5.  Gelsolin activity controls efficient early HIV-1 infection.

Authors:  Laura García-Expósito; Serena Ziglio; Jonathan Barroso-González; Laura de Armas-Rillo; María-Soledad Valera; Donato Zipeto; José-David Machado; Agustín Valenzuela-Fernández
Journal:  Retrovirology       Date:  2013-04-10       Impact factor: 4.602

Review 6.  RNA Structures and Their Role in Selective Genome Packaging.

Authors:  Liqing Ye; Uddhav B Ambi; Marco Olguin-Nava; Anne-Sophie Gribling-Burrer; Shazeb Ahmad; Patrick Bohn; Melanie M Weber; Redmond P Smyth
Journal:  Viruses       Date:  2021-09-08       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.